Therefore, it can be seen that high levels of OCT-1 expression in breast tumors disturb many cellular processes, with disorders resulting from it possibly contributing to malignization, higher tumor aggressiveness, and higher tumor resistance to chemotherapeutics. This evidence concerns the gene POU2F1 and neoplasm.